<DOC>
	<DOCNO>NCT01394133</DOCNO>
	<brief_summary>Data suggest woman take drug treat human immunodeficiency virus ( HIV ) high amount drug body compare men take dose anti-HIV drug . The reason high drug exposure yet determine . The primary purpose study examine whether pharmacokinetics ( factor determine amount drug body ) anti-HIV drug change different phase menstrual cycle woman ultimately result high amount drug body compare men . In word , plan examine whether change sex hormone throughout menstrual cycle affect amount anti-HIV drug HIV infect woman . The antiretroviral drug atazanavir , ritonavir , tenofovir emtricitabine study .</brief_summary>
	<brief_title>Impact Menstrual Cycle Antiretroviral Pharmacokinetics HIV-Infected Women</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>HIV positive female 2140 year age . Subjects must receive antiHIV regimen consist tenofovir , emtricitabine , atazanavir , ritonavir minimum 4 week prior study . Subjects must regular menstrual cycle ( period ) , define least 10 cycle year , occur approximately every 28 days+/ 4 day cycle length vary 7 day . Subjects breast feeding , pregnant , take oral contraceptive ( birth control pill ) least 3 month prior study . Subjects may intrauterine device ( IUD ) , Mirena , place prevent pregnancy .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>HIV Infected Women</keyword>
</DOC>